Recent Publications by Several Independent Laboratories Show ADG20 Has Neutralizing Activity with Potency Comparable to Other Antibodies that Retain Activity Against Omicron Multiple Efforts Underway to Address Omicron and Potential Future SARS-CoV-2 Variants WALTHAM, Mass., Jan. 12, 2022 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., (Nasdaq: ADGI), a clinical-stage biopharmaceutical company

NEW YORK, Jan. 11, 2022 (GLOBE NEWSWIRE) — Madison Realty Capital (“Madison”) today announced the final close of Madison Realty Capital Debt Fund V LP (“Fund V”), raising $2.08 billion in equity commitments, exceeding the fund’s $1.75 billion target. Fund V received significant support from existing investors as approximately 70%

Rancho Santa Margarita, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) — Following food authority EFSA’s ban of food additive titanium dioxide (TiO2), Blue California, the producer of natural science-based ingredients, launched novel food-grade whitening agents as a clean-label alternative to replacing potential health risk white colorant titanium dioxide. “Brands that seek

Issued by the German Federal Office for Information Security, the Certification Reinforces Zoom’s Commitment to Security SAN JOSE, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM) today announced that Zoom Meeting Client version 5.6.6 has become the first video communications client to attain certification for

BOSTON and SHANGHAI, China, Jan. 06, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and delivery of immune-based therapies, today announced the appointment of John Orloff, MD to its Board of Directors. Dr. Orloff joins the Zenas Board with over

Bedford, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) — Conagen, the Massachusetts-based biotechnology innovator, announced the successful development of antioxidant kaempferol produced by state-of-the-art, proprietary, precision fermentation. As a biotechnology company specializing in developing commercially valuable molecules for its partners and clients, Conagen’s kaempferol enables brands in nutrition, beauty, and personal

OTTAWA, Ontario and CAMBRIDGE, United Kingdom, Jan. 04, 2022 (GLOBE NEWSWIRE) — Harris, a global vertical market software provider, has acquired the i2 intelligence analysis product portfolio of IBM, including the i2 Analyst’s Notebook, i2 Enterprise Insight Analysis (EIA) and i2 iBase platforms. The acquisition positions Harris to further deliver

New addition strengthens executive management team of Amsterdam based global network company AMSTERDAM, The Netherlands, Jan. 04, 2022 (GLOBE NEWSWIRE) — Expereo, the world’s leading provider of Global Internet, Cloud Access Optimization, SASE, and SD-WAN services, has today announced the appointment of Ben Elms as Chief Revenue Officer. Elms’ s